A Study of Axl Inhibitor FC084CSA in Patients With Advanced Malignant Solid Tumors

Clinical trial NCT06231550 · COMPLETED

Trial details

NCT number: NCT06231550
Sponsor: FindCure Biosciences (ZhongShan) Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Solid Tumors

Start date: 2023-03-01
Primary completion: 2025-03-18
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.